We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Neuroscience News & Research

Neuroscience News & Research

eXmoor pharma

We are eXmoor, a leading technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.

Latest Content

3D illustration of a pipette injecting material into a cell, symbolizing cell therapy.

eXmoor Pharma and Siam Bioscience Form Strategic Partnership To Establish Leading Cell and Gene Therapy Services in Southeast Asia

eXmoor and Siam Bioscience partner to build Thailand’s leading CGT hub, boosting regional innovation and patient access.

Double helix structure of DNA and a test tube.

eXmoor and Virica Receive Funding To Improve AAV Gene Therapy Manufacturing

eXmoor pharma, and Virica Biotech Inc. (“Virica”), announced a new project funded in part through a joint Canada-UK government biomanufacturing collaboration.

T cells.

Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor Pharma

Quell Therapeutics Ltd (“Quell” or “the Company”), and eXmoor pharma (“eXmoor”), announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune diseases.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter